Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis (NOV, 10.1007/s11154-024-09928-3, 2024)


Por: Biagetti, B, Araujo-Castro, M, Tebe, C, Marazuela, M and Puig-Domingo, M

Publicada: 27 nov 2024 Ahead of Print: 1 nov 2024
Resumen:


Filiaciones:
Biagetti, B:
 Hosp Univ Vall Hebron, Endocrinol & Nutr Dept, CIBERER U747, ISCIII,ENDO ERN, Barcelona, Spain

Araujo-Castro, M:
 Hosp Univ Ramon y Cajal, Inst Invest Biomed Ramon y Cajal IRYCIS, Dept Endocrinol & Nutr, Madrid, Spain

:
 Germans Trias & Pujol Res Inst & Hosp IGTP, Biostat Support & Res Unit, Badalona, Spain

Marazuela, M:
 Hosp Univ La Princesa Madrid, Endocrinol & Nutr Dept, Madrid, Spain

:
 Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Endocrinol & Nutr Dept, CIBERER U747,ISCIII, Badalona, Spain
ISSN: 13899155





REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Editorial
Kluwer Academic Publishers, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, Países Bajos
Tipo de documento: Correction
Volumen: Número:
Páginas:
WOS Id: 001366238600001
ID de PubMed: 39602053
imagen hybrid

MÉTRICAS